Skip to content
All news
Analysis

Palantir Stock Price 2030: Measured Recovery, No Moonshot

After a euphoric run and a sharp 2026 decline, 24/7 Wall St.'s proprietary model sees a gradual recovery for Palantir (PLTR) by 2030, without extraordinary returns.

May 15, 2026
2 min read
Source: 24/7 Wall St.
Share:

Palantir (PLTR) Stock Price in 2030: Measured Recovery, No Moonshot

Palantir Technologies (NASDAQ:PLTR) remains one of the most polarizing names in the AI trade, with that tension clearly reflected in its price action. Following a euphoric rally, the stock has cooled sharply in 2026, and 24/7 Wall St.'s proprietary model now points to a measured recovery rather than a moonshot.

Rating Change

The report does not issue an explicit buy or sell rating, but suggests the stock may have peaked in its previous rally and that current valuations remain elevated relative to fundamentals.

Analyst Rationale

The model assumes Palantir will continue to grow, but at a slower pace than the market expects. Key factors include:

  • Slowing revenue growth as government contracts mature.
  • Increasing competition in data analytics software.
  • Difficulty achieving high operating margins.

Context

The stock's 2026 performance has been disappointing, losing over 40% from its peak. Other Wall Street analysts are divided: some see the stock as undervalued after the correction, while others believe valuations remain stretched.

What We Conclude

The report does not offer a buy or sell recommendation, but advises caution. Investors interested in AI may find better opportunities in companies with more reasonable valuations. It is important to monitor Palantir's quarterly results to gauge whether it meets growth expectations.

Frequently Asked Questions

The report does not give a specific price target, but suggests a gradual recovery without extraordinary returns.

Found this useful? Share it

Share:
This article was rewritten in Wrqti's editorial style based on information from the original source above. Content is informational only — not investment advice.